Evidence map›Paper›PMID 42641877›Full record

ArticleMolecular metabolism2026

Intermittent time-restricted feeding recapitulates the physiological benefits of daily time-restricted feeding in male mice with chronic metabolic disease.

Andre Sarmento-Cabral, Marta G Novelle, Luz Marina Sánchez-Mendoza, Natalia Herman-Sanchez, Samanta Lozano de la Haba, Marta Rodriguez-Vazquez, Pablo Iturbe, Eduardo Chicano-Gálvez, Francisco Javier Cubero, Raul M Luque and 5 more

Abstract read
In one paragraph

Article in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andre Sarmento-CabralDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain.
Marta G NovelleDepartment of Genetics, Physiology and Microbiology (Unity of Animal Physiology), Faculty of Biological Sciences, Complutense University of Madrid (UCM), Madrid, Spain.
Luz Marina Sánchez-MendozaDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain.
Natalia Herman-SanchezDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain.
Samanta Lozano de la HabaDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain.
Marta Rodriguez-VazquezDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain.
Pablo IturbeLaboratory of Cellular and Molecular Gerontology, Precision Nutrition and Aging, Institute IMDEA Nutrition, CEI UAM+CSIC, 28049 Madrid, Spain.
Eduardo Chicano-GálvezMaimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain; IMIBIC Mass Spectrometry and Molecular Imaging Unit (IMSMI), 14004 Córdoba, Spain.
Francisco Javier CuberoCIBEREHD (Center for Biomedical Network Research in Liver and Digestive Diseases), Instituto de Salud Carlos III, 28029 Madrid, Spain; Department of Immunology, Ophthalmology and ORL, Complutense University School of Medicine, Madrid, Spain; Health Research Institute Gregorio Marañón (IiSGM), Madrid, Spain.
Raul M LuqueDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Madrid, Spain.
Jose Cordoba-ChaconDepartment of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Juan L Lopez-CanovasDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Madrid, Spain.
Jose M VillalbaDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain.
Manuel D GaheteDepartment of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Spain; Reina Sofía University Hospital, University of Córdoba, 14004 Córdoba, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Madrid, Spain. Electronic address: bc2gaorm@uco.es.
Alberto Diaz-RuizLaboratory of Cellular and Molecular Gerontology, Precision Nutrition and Aging, Institute IMDEA Nutrition, CEI UAM+CSIC, 28049 Madrid, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Madrid, Spain. Electronic address: alberto.diazruiz@nutricion.imdea.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Time-restricted feeding (TRF) is proposed as a relevant strategy to counteract obesity and metabolic disorders; however, the therapeutic efficacy of more pragmatic intermittent TRF (iTRF) regimens remains undefined. Herein, daily and intermittent TRF significantly improved whole-body physiology, promoted key hallmarks of energy restriction, and induced coordinated transcriptional and lipidomic remodeling in male mice with chronic metabolic dysfunction previously established by prolonged high-fat, high-cholesterol, high-fructose feeding. These effects were summarized using three composite scores capturing physiological/metabolic, energy restriction, and lipidic responses, which consistently separated daily and intermittent TRF regimens from ad libitum-fed mice. Lipidomic profiling identified a subset of hepatic lipids associated with systemic health, pointing to lipid remodeling, particularly at the endoplasmic reticulum, as a potential feature of the TRF response. Notably, TRF failed to histologically improve hepatic steatosis, ballooning, or inflammation, and its overall benefits were clearly inferior to dietary normalization to standard chow diet. Altogether, these data (i) demonstrate that intermittent TRF recapitulates the beneficial effects in advanced metabolic disease, (ii) provides translational support for flexible TRF strategies, and (iii) highlights the need to integrate TRF with additional therapeutic strategies.

Indexed as

LipidomicsMetabolic homeostasisTime-restricted feedingWhole-body physiology

Identifiers

PMID42641877
PMCPMC13587810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.